Active	Status	Sponsor type	Region	Phase	Filter
4 Active 0 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Pan, Yunfeng
NCT06145893: A Study of Efficacy and Safety of Hemay005 Tablets in Patients With Behçet's Disease	Recruiting	3	162	RoW	Hemay005, Mufemilast, Phosphodiesterase 4 (PDE4) inhibitors, Placebo	Ganzhou Hemay Pharmaceutical Co., Ltd	Behçet's Disease	11/24	03/25
BEconneCTD-ILD, NCT06572384: A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease	Recruiting	3	440	Europe, Japan, US, RoW	Belimumab, BENLYSTA, GSK1550188, Placebo	GlaxoSmithKline	Lung Diseases, Interstitial	10/28	12/28
NCT06250062: A Clinical Study of JS005 in Patients With Ankylosing Spondylitis	Recruiting	2	261	RoW	Recombinant humanized IL-17A Monoclonal Antibody（JS005）, Placebo（JS005）	Shanghai Junshi Bioscience Co., Ltd., Sponsor GmbH	Ankylosing Spondylitis	02/25	10/25
NCT05849727: A Clinical Study of TQH3821 Tablets in the Treatment of Treated Rheumatoid Arthritis	Recruiting	2	180	RoW	TQH3821 tablets 200 mg, TQH3821 tablets matching placebo	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	Rheumatoid Arthritis	06/24	12/24